We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Cardiovascular Mortality Associated With Abnormal Calcium Metabolism

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00018395
First Posted: July 5, 2001
Last Update Posted: January 21, 2009
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
VA Office of Research and Development
July 3, 2001
July 5, 2001
January 21, 2009
August 1997
Not Provided
Not Provided
Not Provided
Complete list of historical versions of study NCT00018395 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Cardiovascular Mortality Associated With Abnormal Calcium Metabolism
Cardiovascular Mortality Associated With Abnormal Calcium Metabolism
The purpose of this cohort study is to estimate the risk of cardiovascular mortality associated with abnormal calcium metabolism
Not Provided
Observational
Not Provided
Not Provided
Not Provided
Not Provided
Not Provided
  • Cardiovascular Disease
  • Kidney Disease
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
Not Provided
June 2002
Not Provided
All ESRD patients who indicated dialysis in 1990-1993
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT00018395
CADE-AI
Not Provided
Not Provided
Not Provided
Not Provided
VA Office of Research and Development
Not Provided
Not Provided
VA Office of Research and Development
December 2004